Platelet-derived growth factor receptor-β, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma
2007

How a Mutation in PDGF Receptor Affects Melanoma Growth

Sample size: 16 publication 10 minutes Evidence: moderate

Author Information

Author(s): Suzuki Shioto, Carl-Henrik Heldin, Rainer Lothar Heuchel

Primary Institution: Ludwig Institute for Cancer Research, Uppsala Branch, Uppsala, Sweden

Hypothesis

Does the activating mutation D849N in PDGF receptor-β influence tumor establishment and growth in melanoma?

Conclusion

The activated PDGFR-β (D849N) in the host animal increased the total vessel area and the average vessel surface, resulting in a shorter lag phase during tumor establishment.

Supporting Evidence

  • Activated PDGFR-β led to earlier tumor establishment in mice.
  • Total vessel area and average vessel surface were higher in tumors from mutant mice.
  • At later stages, tumor growth rates were similar between wild type and mutant mice.

Takeaway

A specific mutation in a protein that helps cells grow made tumors grow faster in mice by improving blood supply.

Methodology

B16 melanoma cells were injected into mice with the D849N mutation and tumor growth was measured and analyzed for vascular characteristics.

Potential Biases

Potential bias in the interpretation of results due to the specific mouse model used.

Limitations

The study primarily focused on early tumor establishment and did not explore long-term tumor behavior beyond a certain size.

Participant Demographics

Mice used were of the C57Bl/6 strain, including both wild type and D849N-mutant.

Statistical Information

P-Value

0.047

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-224

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication